Cell Communication and Signaling Молекулярная биология

The MAGOH/hnRNPH1 axis promotes alternative splicing-derived soluble PD-L1 generation and attenuates PD-L1 blockade efficacy in gastric cancer

Jiang, Kecheng, Chen, Cheng, Li, Yuntong, Yu, Shanshan, Zhou, Donghui
Springer Nature · 2026-11-17 · DOI 10.1186/s12964-026-03379-w

Аннотация

Despite the clinical success of PD-1 blockade, the therapeutic efficacy of PD-L1 blockade in gastric cancer (GC) remains limited. Soluble PD-L1 (sPD-L1) has been proposed to function as a decoy that sequesters anti-PD-L1 antibodies, potentially contributing to therapeutic resistance. Our previous study identified an exon 5/6-skipping PD-L1 splice variant, designated PD-L1-v1, as an important source of sPD-L1 in GC. We also found that MAGOH is highly expressed in GC and participates in alternative splicing regulation. Here, we demonstrate that PD-L1-v1 acts as a soluble decoy that limits PD-L1 blocker binding to membrane-bound PD-L1 on tumor cells, thereby impairing the antitumor efficacy of PD-L1 blockade. Mechanistically, MAGOH upregulates hnRNPH1 expression, primarily by enhancing its mRNA stability, and promotes hnRNPH1-dependent exon5/6 skipping of PD-L1 pre-mRNA, thereby facilitating PD-L1-v1 and sPD-L1 generation. These findings reveal a previously unrecognized mechanism of resistance to PD-L1 blockade and highlight the MAGOH/hnRNPH1 axis as a potential strategy for improving immunotherapy efficacy in GC.

Читать у издателя →